Beware of unapproved stem cell procedures – UC Davis study looks at businesses selling “stem cell” interventions for variety of injuries and diseases

UC Davis School of Medicine news release At least 351 companies across the United States are marketing unapproved stem cell procedures, according to a new study by a UC Davis stem cell researcher and a University of Minnesota bioethicist. In their paper, Paul Knoepfler and Leigh Turner present an analysis of U.S. businesses engaged in…